Global burden of gout in 1990-2019: A systematic analysis of the Global Burden of Disease study 2019.

Journal: European journal of clinical investigation

Volume: 53

Issue: 4

Year of Publication: 2023

Affiliated Institutions:  Yonsei University College of Medicine, Seoul, Korea. Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea. Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, Korea. Laboratory of Microorganisms and Active Biomolecules, Sciences Faculty of Tunis, University Tunis El Manar, Tunis, Tunisia. Research and Development Unit, Parc Sanitari Sant Joan de Deu, CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain. University Hospital, Philipps University of Marburg, Marburg, Germany. Pain and Rehabilitation Centre, and Department of Health, Medicine and Caring Sciences, Linkoping University, Linkoping, Sweden. August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Mental Health Research Networking Center (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain. Stockholm Center for Health and Social Change (SCOHOST), Södertörn University, Huddinge, Sweden. Suzanne Dworak Peck School of Social Work, University of Southern California, California, Los Angeles, USA. Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea. Centre for Health, Performance, and Wellbeing, Anglia Ruskin University, Cambridge, UK.

Abstract summary 

Although gout is one of the most common rheumatic diseases, world data are lacking because most studies have focused on industrialized countries. Therefore, we aimed to investigate the global burden of gout and its associations with the year of diagnosis, age, geographical region, sociodemographic status and various further risk factors.Retrospective data from the Global Burden of Disease (GBD) were used, initially collected between 1990 and 2019. Raw numbers and age-standardized rates (per 100,000 persons) of prevalence, incidence and years lived with disability (YLDs) of gout were extracted from GBD 2019 for 204 countries and territories and stratified by sex, age, year, sociodemographic index and geographic region. Correlations between gout and other chronic diseases were identified, and the burden attributable to high body mass index (BMI) and kidney dysfunction was described.The total number of patients and gout age-standardized prevalence rate increased between 1990 and 2019. Gout was most prevalent in Australasia and high-income North America, and a higher sociodemographic index (SDI) was associated with higher age-standardized prevalence, incidence and YLDs. High BMI and kidney dysfunction were risk factors for gout, while gout was correlated with other kidney diseases.The global prevalence of gout, as well as incidence, and YLDs increased worldwide from 1990 to 2019 and had a significant association with sex, age, geographic region, SDI and risk factors. Understanding the complex interplay of environmental, sociodemographic and geographic risk factors is essential in mitigating the ever-rising disease burden of gout.

Authors & Co-authors:  Jeong Yeon Jae YJ Park Seoyeon S Yon Dong Keon DK Lee Seung Won SW Tizaoui Kalthoum K Koyanagi Ai A Jacob Louis L Kostev Karel K Dragioti Elena E Radua Joaquim J Stickley Andrew A Oh Hans H Shin Jae Il JI Smith Lee L

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Ther. 2010;12(2):1-8.
Authors :  14
Identifiers
Doi : 10.1111/eci.13937
SSN : 1365-2362
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
disease burden;global health;obesity;prevalence of gout;sociodemographic index (SDI)
Study Design
Cross Sectional Study
Study Approach
Systemic Review
Country of Study
Publication Country
England